mybacs vs Xbiome
mybacs
Support gut health with one capsule a day. Do it daily to boost digestion, energy, and overall wellness
66 employees · est. 2019 · Zug, Switzerland
Xbiome
China's leading AI-driven microbiome drug development company
51 employees · est. 2017 · Cambridge, United States
Xbiome is the older company (2019 vs 2017).
4 signals in the last 90 days
Side-by-Side Comparison
| Metric | mybacs | Xbiome |
|---|---|---|
| Founded | ||
| Founded | 2019 | 2017 older |
| Headquarters | ||
| Headquarters | Zug, Switzerland | Cambridge, United States |
| Employees | ||
| Employees | 66 | 51 |
| Industry | ||
| Industry | Biotechnology, Pharmaceutical | AI, Biotechnology, Pharmaceutical |
| Funding Stage | ||
| Funding Stage | Series A | Series B |
| Total Funding | ||
| Total Funding | $5.90M | $210.00M |
| Funding Rounds | ||
| Funding Rounds | 4 | 4 |
| Services | ||
| Services | Probiotic Supplements, Prebiotic and Postbiotic Products, Nutritional Drinks, Health and Wellness Education, Online Shopping Platform | Technology Platform Development, Pharmaceutical Research, Drug Pipeline Management, Collaboration with Scientific and Medical Communities |
| Target Customers | ||
| Target Customers | Women seeking health supplements, Individuals interested in gut health, Health-conscious consumers, Returning customers through loyalty programs | Biotech and Pharma Companies, Healthcare Organizations, Research Institutions, Scientific Community |
| Taxonomy | ||
| Taxonomy | Gut HealthMicrobiomeIntestinal HealthcareSynbiotic SupplementsProbiotic CulturesPrebiotics +9 | AI-driven Drug DevelopmentMicrobiome TherapeuticsGut Health ManagementPersonalized MedicineBioinformaticsMicrobial Technology +8 |
| Website | ||
| Website | mybacs.com | xbiome.com |
About mybacs
mybacs is a research-driven direct-to-consumer company specializing in the human microbiome, headquartered in Zug, Switzerland. It caters to individuals interested in gut health and health-conscious consumers, offering synbiotic supplements tailored to their needs. Founded in 2019, mybacs focuses o...
About Xbiome
Xbiome, established in 2017, is touted as China's leading AI-driven microbiome drug development company. As a pioneer in AI-based solutions, it aims to transform the biotechnology and pharmaceutical sectors, focusing on gut microbiome using sophisticated AI techniques. This approach to health levera...
Also comparing in this category
Comparing more than these two?
Get mybacs, Xbiome and up to nine more competitors side by side in one PDF: team, funding, traffic and every dated move of the last six months. Every company is re-checked on the day you order.
How does mybacs compare?
A PDF of mybacs and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.
This takes a few seconds: we look beyond our own index too.
Frequently Asked Questions
Compare mybacs with someone else
Start typing a company name or domain.
Related Comparisons
Compiled from the BounceWatch company index. We last looked at mybacs on 1 Oct 2026, and Xbiome on 15 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.
